#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Candida infection Diffuse large B-cell lymphoma recurrent Spinal muscular atrophy Pituitary-dependent Cushing's syndrome Vulval cancer Autoimmune myositis Heavy menstrual bleeding Factor IX deficiency Krabbe's disease Drug eruption Synovial sarcoma metastatic Mantle cell lymphoma stage III Fontan procedure Demyelination Gaucher's disease type III More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis II – Diagnostics Systemic sclerosis pulmonary – Trials in Disease Hairy cell leukaemia – Diagnostics Haemophilia A with anti factor VIII – Trials in Disease Retinitis pigmentosa – Basic Information Haemophilia A without inhibitors – Trials in Disease Progressive multifocal leukoencephalopathy – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Antithrombin III deficiency Gastrointestinal stromal tumour – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lebrikizumab Gskvx000000008866 Corline Heparin Conjugate Calcipotriol AZD0516 Nimotuzumab Azd0305 Azd2693 Sodium Indapamide Inaxaplin Glpg3667 Fumarate Lisinopril Dihydrate Ritonavir ALKYLATING AGENTS Gs-1427 Baxdrostat Oxogluric Acid T89 Palonosetron Hydrochloride Rtx001 More therapies…

    Learn about Your Condition

    Retinal neovascularisation Laryngeal leukoplakia Cervix carcinoma stage III Fungal infection Eye pain Hodgkin's disease refractory Osteogenesis imperfecta Endocrine disorder Breast proliferative changes Anaemia Athetosis Oedema Gaucher's disease type III Exudative retinopathy Hypertrophic scar More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Vemurafenib, Cobimetinib, and Atezolizumab for Patients with High-Risk, Surgically Removable BRAF Mutated and Wild-Type Melanoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Atezolizumab
    • Cobimetinib
    • Vemurafenib
    Italy

  • Study on Morning vs. Evening Dosing of Tofacitinib for Patients with Rheumatoid or Psoriatic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tofacitinib
    The Netherlands

  • Study on the Effectiveness of Spinal Anesthesia vs. Sedation for Turning Breech Babies: Comparing Midazolam and Bupivacaine in Pregnant Women

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bupivacaine Hydrochloride, Anhydrous
    • Midazolam
    France

  • Study on Everolimus for Preventing Rejection in Adult Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal failure
    Investigated Drugs:
    • Everolimus
    France

  • Study on the Effects of GSL-01-001 for Patients with Irritable Bowel Syndrome (IBS) Type D

    Recruiting

    2 1 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Investigated Drugs:
    • Cannabidiol
    Poland

  • Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
    • Bay 2927088
    • SEVABERTINIB
    Austria Belgium Bulgaria Czechia Denmark Finland +12
Previous Page
1 … 384 385 386 387 388 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!